|
1
|
Prochazka V, Papajik T, Jarosova M and
Indrak K: Prognostic factors in follicular lymphoma in the
rituximab era: How to identify a high-risk patient? Biomed Pap Med
Fac Univ Palacky Olomouc Czech Repub. 155:99–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martinez-Climent JA, Alizadeh AA, Segraves
R, Blesa D, Rubio-Moscardo F, Albertson DG, Garcia-Conde J, Dyer
MJ, Levy R, Pinkel D and Lossos IS: Transformation of follicular
lymphoma to diffuse large cell lymphoma is associated with a
heterogeneous set of DNA copy number and gene expression
alterations. Blood. 101:3109–3117. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shipp MA, Ross KN, Tamayo P, Weng AP,
Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, et
al: Diffuse large B-cell lymphoma outcome prediction by
gene-expression profiling and supervised machine learning. Nat Med.
8:68–74. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ,
Wang CY, Zhang HM, Zhang RX, Zhang JJ, et al: lncRNA HULC enhances
epithelial-mesenchymal transition to promote tumorigenesis and
metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1
signaling pathway. Oncotarget. 7:42431–42446. 2016.PubMed/NCBI
|
|
5
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hangauer MJ, Vaughn IW and McManus MT:
Pervasive transcription of the human genome produces thousands of
previously unidentified long intergenic noncoding RNAs. PLoS Genet.
9:e10035692013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim T, Cui R, Jeon YJ, Fadda P, Alder H
and Croce CM: MYC-repressed long noncoding RNAs antagonize
MYC-induced cell proliferation and cell cycle progression.
Oncotarget. 6:18780–18789. 2015.PubMed/NCBI
|
|
8
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang JY, Lee JC, Chang YT, Hou MF, Huang
HW, Liaw CC and Chang HW: Long noncoding RNAs-related diseases,
cancers, and drugs. ScientificWorldJournal. 2013:9435392013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dijkstra S, Mulders PF and Schalken JA:
Clinical use of novel urine and blood based prostate cancer
biomarkers: A review. Clin Biochem. 47:889–896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ariel I, Miao HQ, Ji XR, Schneider T, Roll
D, de Groot N, Hochberg A and Ayesh S: Imprinted H19 oncofetal RNA
is a candidate tumour marker for hepatocellular carcinoma. Mol
Pathol. 51:21–25. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giza DE, Vasilescu C and Calin GA:
MicroRNAs and ceRNAs: Therapeutic implications of RNA networks.
Expert Opin Biol Ther. 14:1285–1293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou M, Diao Z, Yue X, Chen Y, Zhao H,
Cheng L and Sun J: Construction and analysis of dysregulated
lncRNA-associated ceRNA network identified novel lncRNA biomarkers
for early diagnosis of human pancreatic cancer. Oncotarget.
7:56383–56394. 2016.PubMed/NCBI
|
|
16
|
Zhou M, Wang X, Shi H, Cheng L, Wang Z,
Zhao H, Yang L and Sun J: Characterization of long non-coding
RNA-associated ceRNA network to reveal potential prognostic lncRNA
biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611.
2016.PubMed/NCBI
|
|
17
|
Yan Y, Han J, Li Z, Yang H, Sui Y and Wang
M: Elevated RNA expression of long non-coding HOTAIR promotes cell
proliferation and predicts a poor prognosis in patients with
diffuse large B cell lymphoma. Mol Med Rep. 13:5125–5131. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng W, Wu J and Feng J: LincRNA-p21
predicts favorable clinical outcome and impairs tumorigenesis in
diffuse large B cell lymphoma patients treated with R-CHOP
chemotherapy. Clin Exp Med. 17:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peng W, Fan H, Wu G, Wu J and Feng J:
Upregulation of long noncoding RNA PEG10 associates with poor
prognosis in diffuse large B cell lymphoma with facilitating
tumorigenicity. Clin Exp Med. 16:177–182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun J, Cheng L, Shi H, Zhang Z, Zhao H,
Wang Z and Zhou M: A potential panel of six-long non-coding RNA
signature to improve survival prediction of diffuse large-B-cell
lymphoma. Sci Rep. 6:278422016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng W, Wu J and Feng J: Long noncoding
RNA HULC predicts poor clinical outcome and represents
pro-oncogenic activity in diffuse large B-cell lymphoma. Biomed
Pharmacother. 79:188–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng W and Feng J: Long noncoding RNA
LUNAR1 associates with cell proliferation and predicts a poor
prognosis in diffuse large B-cell lymphoma. Biomed Pharmacother.
77:65–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou M, Zhao H, Xu W, Bao S, Cheng L and
Sun J: Discovery and validation of immune-associated long
non-coding RNA biomarkers associated with clinically molecular
subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer.
16:162017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brodtkorb M, Lingjaerde OC, Huse K, Trøen
G, Hystad M, Hilden VI, Myklebust JH, Leich E, Rosenwald A, Delabie
J, et al: Whole-genome integrative analysis reveals expression
signatures predicting transformation in follicular lymphoma. Blood.
123:1051–1054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen X, Xie B, Ma Z, Yu W, Wang W, Xu D,
Yan X, Chen B, Yu L, Li J, et al: Identification of novel long
non-coding RNAs in triple-negative breast cancer. Oncotarget.
6:21730–21739. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Crea F, Watahiki A, Quagliata L, Xue H,
Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, et al:
Identification of a long non-coding RNA as a novel biomarker and
potential therapeutic target for metastatic prostate cancer.
Oncotarget. 5:764–774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wan X, Huang W, Yang S, Zhang Y, Pu H, Fu
F, Huang Y, Wu H, Li T and Li Y: Identification of
androgen-responsive lncRNAs as diagnostic and prognostic markers
for prostate cancer. Oncotarget. 7:60503–60518. 2016. View Article : Google Scholar : PubMed/NCBI
|
